It is prescribed for individuals with obesity or those who have weight-related health conditions
showed that liraglutide 3.0 mg/day significantly decreased body weight, BMI, WC and Waist to Hip ratio (W/H) compared with the placebo group [62]
Some people research BPC-157 for: Although animal studies and early research appear promising, more large-scale human research is still needed
Portion-Controlled, Nutrient-Dense Meals Designed for GLP-1 Users GLP-1 medications often lead to reduced hunger cues and smaller appetites, which can make it hard to get the right nutrients in smaller portions
(Recent studies support this, too.) Metformin, another diabetes medication, has already been shown to have this effect in women with PCOS, so it isnt surprising that GLP-1 RAs would have this effect, she adds